US2014308315A1PendingUtilityA1

Apparatus, system, and method for creating immunologically enhanced spaces in-vivo

Assignee: KNEZEVICH CHARLESPriority: Feb 28, 2009Filed: Apr 14, 2014Published: Oct 16, 2014
Est. expiryFeb 28, 2029(~2.6 yrs left)· nominal 20-yr term from priority
A61K 38/193A61L 27/3804A61K 38/20A61K 2039/60A61K 9/5073A61K 35/74A61K 39/385A61P 35/00A61P 31/04A61L 31/005A61P 37/04A61P 31/12A61K 40/428A61K 40/24A61K 40/19C07K 17/04C07K 14/47A61M 5/14A61K 38/17A61K 2039/5154A61K 39/0011
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention creates an immunologically protected/enhanced space in vivo in a mammal by removing the impact of soluble inhibitors of the mammal's immune system in a defined space within the body. Placing an antigen source within the defined protected space along with a monocyte-containing blood sample from the mammal being treated and a dendritic cell-inducing factor allows a dendritic-antigen presentation process to proceed to completion. The protected/enhanced space is created by surrounding the protected space with ligands which absorb and/or bind to one or more soluble inhibitors. The implant can be loaded with a patient's cancer cells to treat cancer.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A method of creating an immunologically protected/enhanced space in vivo in a mammal which comprises:
 a) removing the impact of soluble inhibitors of the mammal's immune system in a defined space within the mammal's body and   b) placing an antigen source within the defined space to allow a dendritic-antigen presentation process to proceed to completion.

Join the waitlist — get patent alerts

Track US2014308315A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.